Pharmaceuticals and healthcare

Bjarne Tellmann pearson

FTSE 100 giant Pearson loses GC to GSK

Pearson’s general counsel is leaving the education publisher to join GlaxoSmithKline’s consumer healthcare business. Bjarne Tellmann – who has been Pearson’s GC for six years – is joining GSK where he will take up the role of senior vice president and general counsel from July. Tellmann joined Pearson in 2014 from the Coca-Cola company, where […]

drugs

Mills & Reeve triumphs for NHS in scrap over pharma drug

In a decision that could potentially save the NHS up to £500m a year, Mills & Reeve and Landmark Chambers yesterday secured a monumental Court of Appeal victory over Arnold & Porter and Covington & Burling, duly defeating two big pharma companies in the process. The contentious rematch saw both Bayer and Novartis fail to […]

Coronovirus in the workplace

US and European firms lead on $11.5bn purchase of disease test kit maker

Wachtell Lipton Rosen & Katz, De Brauw Blackstone Westbroek, Linklaters and Hengeler Mueller all picked up roles on the $11.5bn acquisition of a German pharmaceutical testing company by a US scientific instruments maker. Wachtell, Hengeler and Dutch firm NautaDutilh acted for Thermo Fisher, which yesterday bought the testing company Qiagen, advised by De Brauw, Linklaters […]

Richard Grimshaw successful in appeal

Richard Grimshaw appeared for the Claimant/Respondent in an appeal concerning the refusal by a district judge to grant relief from sanctions to the Defendant/Appellant in a moderately high value and complex clinical negligence case. The Defendant applied for an extension of time to serve a witness statement from a clinician after the deadline for exchanging […]

Clinical negligence trial sees damages awarded of £1.5m in Cauda Equina syndrome case

Clinical negligence experts from No5 Barristers’ Chambers have seen the successful conclusion of a claim involving Cauda Equina Syndrome with damages agreed at around £1.5million. Jonathan Jones QC and David Tyack, with Moosa Duke solicitors, represented the claimant, 37, who had a long history of back pain. The defendant NHS Trust was represented by Michael […]

Fieldfisher

Fieldfisher loses third life sciences partner in four months

Fieldfisher has lost a London partner to US firm Arnold & Porter, in a move that marks yet another blow to Fieldfisher’s IP and life sciences practice following a string of departures. Partner Beatriz San Martin has joined the US firm having spent over a decade at Fieldfisher. She joined in 2004 and ascended to […]

DLA Piper roundtable: Dealing with the rise of digital therapeutics

The Lawyer, in association with DLA Piper, recently hosted a roundtable focusing on the growing number of obstacles and opportunities faced by law firms and businesses alike when working with digital therapeutics Co-moderators Roger Wagland – Research and digital product director, The LawyerTom Heylen – partner, DLA Piper Gareth Stokes – partner, DLA Piper Round […]

Novartis keeps firms waiting for results of global panel review

Swiss pharmaceutical powerhouse Novartis is nearing the end of its global legal panel review, which is understood to have been launched earlier this year. The panel is underway following the appointment of GC Shannon Thyme Klinger, who took on the role in June 2018, replacing Felix Ehrat. Her appointment came four months after Novartis also […]

Kirkland among US firms acting on $90bn pharma merger

Kirkland & Ellis, Sullivan & Cromwell and Arnold & Porter Kaye Scholer are the firms involved in the latest deal between US pharmaceutical giants, Bristol-Myers Squibb, Celgene and Amgen, valued at $13.4bn. The deal is related to the $90bn merger between the Bristol-Myers Squibb and Celgene, announced in January, and the sale of Celgene’s skin […]